Cargando…
Antibody Directed against Human YKL-40 Increases Tumor Volume in a Human Melanoma Xenograft Model in Scid Mice
Induced overexpression of the secretory protein YKL-40 promotes tumor growth in xenograft experiments. We investigated if targeting YKL-40 with a monoclonal antibody could inhibit tumor growth. YKL-40 expressing human melanoma cells (LOX) were injected subcutenously in Balb/c scid mice. Animals were...
Autores principales: | Salamon, Johannes, Hoffmann, Tatjana, Elies, Eva, Peldschus, Kersten, Johansen, Julia S., Lüers, Georg, Schumacher, Udo, Wicklein, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994147/ https://www.ncbi.nlm.nih.gov/pubmed/24752554 http://dx.doi.org/10.1371/journal.pone.0095822 |
Ejemplares similares
-
YKL-40 protein expression in human tumor samples and human tumor cell line xenografts: implications for its use in tumor models
por: Böckelmann, Lukas Clemens, et al.
Publicado: (2021) -
CEACAM1 promotes melanoma metastasis and is involved in the regulation of the EMT associated gene network in melanoma cells
por: Wicklein, Daniel, et al.
Publicado: (2018) -
E- and P-Selectins Are Essential for Repopulation of Chronic Myelogenous and Chronic Eosinophilic Leukemias in a Scid Mouse Xenograft Model
por: Wicklein, Daniel, et al.
Publicado: (2013) -
Serum YKL-40 and colorectal cancer
por: Cintin, C, et al.
Publicado: (1999) -
Nilotinib and Imatinib Are Comparably Effective in Reducing Growth of Human Eosinophil Leukemia Cells in a Newly Established Xenograft Model
por: Wicklein, Daniel, et al.
Publicado: (2012)